CNA Financial’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-300,000
| Closed | -$8.64M | – | 20 |
|
|
2023
Q4 | $8.64M | Buy |
+300,000
| New | +$9.07M | 5.67% | 9 |
|
|
2022
Q1 | – | Sell |
-150,000
| Closed | -$8.86M | – | 198 |
|
|
2021
Q4 | $8.86M | Sell |
150,000
-50,000
| -25% | -$2.48M | 2.32% | 10 |
|
|
2021
Q3 | $8.6M | Buy |
+200,000
| New | +$8.86M | 2.34% | 7 |
|
|
2020
Q1 | – | Sell |
-92,768
| Closed | -$3.45M | – | 152 |
|
|
2019
Q4 | $3.45M | Sell |
92,768
-34,524
| -27% | -$1.23M | 0.93% | 29 |
|
|
2019
Q3 | $4.34M | Sell |
127,292
-57,535
| -31% | -$2.09M | 0.97% | 28 |
|
|
2019
Q2 | $7.6M | Buy |
184,827
+37,404
| +25% | +$1.49M | 1.58% | 13 |
|
|
2019
Q1 | $5.94M | Hold |
147,423
| – | – | 1.26% | 19 |
|
|
2018
Q4 | $6.11M | Sell |
147,423
-49,139
| -25% | -$2.04M | 1.32% | 20 |
|
|
2018
Q3 | $8.22M | Hold |
196,562
| – | – | 1.7% | 12 |
|
|
2018
Q2 | $6.77M | Hold |
196,562
| – | – | 1.49% | 13 |
|
|
2018
Q1 | $6.62M | Sell |
196,562
-64,199
| -25% | -$2.21M | 1.41% | 14 |
|
|
2017
Q4 | $8.96M | Hold |
260,761
| – | – | 2.16% | 10 |
|
|
2017
Q3 | $8.83M | Buy |
260,761
+63,952
| +32% | +$2.06M | 2.23% | 8 |
|
|
2017
Q2 | $6.27M | Sell |
196,809
-31,620
| -14% | -$997K | 1.48% | 14 |
|
|
2017
Q1 | $7.41M | Buy |
228,429
+54,001
| +31% | +$1.7M | 1.64% | 13 |
|
|
2016
Q4 | $5.38M | Sell |
174,428
-52,700
| -23% | -$1.61M | 1.2% | 20 |
|
|
2016
Q3 | $7.3M | Hold |
227,128
| – | – | 1.68% | 10 |
|
|
2016
Q2 | $7.59M | Hold |
227,128
| – | – | 1.89% | 7 |
|
|
2016
Q1 | $6.39M | Buy |
227,128
+31,620
| +16% | +$903K | 1.72% | 9 |
|
|
2015
Q4 | $5.99M | Sell |
195,508
-6,534
| -3% | -$206K | 1.6% | 13 |
|
|
2015
Q3 | $6.02M | Hold |
202,042
| – | – | 1.49% | 16 |
|
|
2015
Q2 | $6.43M | Sell |
202,042
-60,916
| -23% | -$1.99M | 1.47% | 12 |
|
|
2015
Q1 | $8.68M | Sell |
262,958
-20,664
| -7% | -$657K | 2.02% | 5 |
|
|
2014
Q4 | $8.38M | Sell |
283,622
-118,612
| -29% | -$3.4M | 1.95% | 7 |
|
|
2014
Q3 | $11.3M | Sell |
402,234
-72,826
| -15% | -$2.04M | 2.17% | 6 |
|
|
2014
Q2 | $13.4M | Buy |
475,060
+167,217
| +54% | +$4.77M | 2.42% | 5 |
|
|
2014
Q1 | $9.38M | Sell |
307,843
-47,430
| -13% | -$1.41M | 1.88% | 9 |
|
|
2013
Q4 | $10.3M | Sell |
355,273
-105,400
| -23% | -$3.07M | 2.02% | 7 |
|
|
2013
Q3 | $12.6M | Buy |
460,673
+51,520
| +13% | +$1.4M | 2.53% | 5 |
|
|
2013
Q2 | $10.9M | Buy |
+409,153
| New | +$11.3M | 2.32% | 7 |
|
Other funds holding PFE
CNA Financial's PFE Position: Q1 2024 in Review
CNA Financial sold out of Pfizer (PFE) in Q1 2024, closing a stake of 300,000 shares — an estimated $8.64M sold.
CNA Financial first reported a position in PFE in Q2 2013 and held it in 30 quarters. The position peaked at $13.4M in Q2 2014. 2,875 funds tracked by Wall St. Rank hold PFE as of Q1 2024.
- CNA Financial reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
- CNA Financial sold 300,000 Pfizer shares in Q1 2024, an estimated $8.64M.
- CNA Financial first reported a position in Pfizer in Q2 2013 and held it in 30 quarters.
- CNA Financial's Pfizer position peaked at $13.4M in Q2 2014.
- 2,875 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.
Based on CNA Financial's 13F filing for Q1 2024, filed 6 May 2024.